![Logo for Allogene Therapeutics Inc](/_next/image?url=https%3A%2F%2Ffiles.quartr.com%2Fcompany-icons%2FpngIcons%2FAllogene%2520Therapeutics%2520Inc%2520-%2520Square.png&w=256&q=100)
Allogene Therapeutics Investor Relations Material
Latest events
![Logo for Allogene Therapeutics Inc](/_next/image?url=https%3A%2F%2Ffiles.quartr.com%2Fcompany-icons%2FpngIcons%2FAllogene%2520Therapeutics%2520Inc%2520-%2520Square.png&w=128&q=100)
Q1 2024
Allogene Therapeutics
Access the full event backlog
Slides, Transcripts, and Reports from 9,000+ public companies
Latest reports from Allogene Therapeutics Inc
Access all reports
Segment Data
Access more data
Revenue by
Source
Collaboration revenue - related party
Expenses by
Financials
Allogene Therapeutics, Inc., a clinical stage immuno-oncology company, develops and commercializes genetically engineered allogeneic T cell therapies for the treatment of cancer. It is developing UCART19, an investigational chimeric antigen receptor T cell product candidate for the treatment of CD19 expressing hematological malignancies; and ALLO-501, an investigational alloCAR T product candidate for the treatment of B-cell non-Hodgkin lymphoma. The company was formerly known as Allogen BioPharma, Inc. and changed its name to Allogene Therapeutics, Inc. in June 2018. Allogene Therapeutics, Inc. was founded in 2017 and is headquartered in South San Francisco, California.
Key slides for Allogene Therapeutics Inc
![Legal Disclaimers
T](/_next/image?url=https%3A%2F%2Fcdn.quartr.com%2Fimages%2Fconference-calls%2Fallogene-therapeutics-inc-investor-presentation-609d33ce01bab3e5%2F2.png&w=3840&q=75)
![Logo for Allogene Therapeutics Inc](/_next/image?url=https%3A%2F%2Ffiles.quartr.com%2Fcompany-icons%2FpngIcons%2FAllogene%2520Therapeutics%2520Inc%2520-%2520Square.png&w=128&q=100)
Investor Presentation
Allogene Therapeutics Inc
![Dagger®Ⓡ Biology : D](/_next/image?url=https%3A%2F%2Fcdn.quartr.com%2Fimages%2Fconference-calls%2Fallogene-therapeutics-inc-investor-presentation-609d33ce01bab3e5%2F16.png&w=3840&q=75)
![Logo for Allogene Therapeutics Inc](/_next/image?url=https%3A%2F%2Ffiles.quartr.com%2Fcompany-icons%2FpngIcons%2FAllogene%2520Therapeutics%2520Inc%2520-%2520Square.png&w=128&q=100)
Investor Presentation
Allogene Therapeutics Inc
Latest articles
![Key](/_next/image?url=https%3A%2F%2Fa.storyblok.com%2Ff%2F182663%2F1882x1059%2F7e17876154%2Fbirkin.png&w=3840&q=75)
The Birkin Bag: The Story Behind the World's Most Desired Handbag
How the Birkin bag became the world's most sought-after handbag where even the wealthy must earn the right to own one.
12 Jul 2024
![Key](/_next/image?url=https%3A%2F%2Fa.storyblok.com%2Ff%2F182663%2F2688x1512%2F8365aa8316%2Ftop-10-largest-semiconductor-companies.png&w=3840&q=75)
The 10 Largest Semiconductor Companies in the World
Discover the top 10 semiconductor companies by market cap, exploring their innovations and business models shaping the tech landscape.
10 Jul 2024
![Key](/_next/image?url=https%3A%2F%2Fa.storyblok.com%2Ff%2F182663%2F2000x1125%2F135c0e3f6b%2Fthe-rise-of-nubank.png&w=3840&q=75)
The Rise of Nubank: Changing Latin American Finance
Discover how Nubank revolutionized Latin American banking with innovation, backed by top investors like Berkshire Hathaway.
9 Jul 2024
Ticker symbol
ALLO
Country
🇺🇸 United States